Abstract
Glucocorticoid-induced hyperglycemia is common in patients with or without known diabetes mellitus. Exenatide, a glucagon-like peptide-1 receptor agonist, improves glycemic control without causing weight gain or hypoglycemia and is currently widely used in patients with type 2 diabetes mellitus. We herein report four cases of patients with type 2 diabetes with worsened glycemic control due to glucocorticoids who were successfully treated with exenatide administration.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Blood Glucose / analysis
-
Blood Glucose / drug effects*
-
Diabetes Mellitus, Type 2 / diagnosis
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Exenatide
-
Female
-
Follow-Up Studies
-
Glucocorticoids / adverse effects*
-
Glucocorticoids / therapeutic use
-
Humans
-
Hyperglycemia / chemically induced*
-
Hyperglycemia / drug therapy
-
Hyperglycemia / physiopathology
-
Hypoglycemic Agents / therapeutic use*
-
Injections, Subcutaneous
-
Insulin / therapeutic use
-
Male
-
Middle Aged
-
Peptides / therapeutic use*
-
Risk Assessment
-
Sampling Studies
-
Treatment Outcome
-
Venoms / therapeutic use*
Substances
-
Blood Glucose
-
Glucocorticoids
-
Hypoglycemic Agents
-
Insulin
-
Peptides
-
Venoms
-
Exenatide